Remove Avalon Remove Marketing Remove Pricing Remove Startup
article thumbnail

Janux Therapeutics Prices IPO, Hits Nasdaq Today

socalTECH

La Jolla-based biopharmaceuticals startup Janux Therapeutics said early this morning that it has priced its IPO, offering up 11,400,000 shares of its common stock at $17.00 The company begins trading this morning on the Nasdaq Global market under the ticker symbol JANX.

Pricing 113
article thumbnail

Interview with Derrick Oien, Intercasting

socalTECH

We seem to receive lots of pitches from companies looking to attack the mobile market with their mobile software applications, but few who have deployed on-deck with carriers. in funding from Venrock, Avalon, and Masthead. Derrick Oien: The primary market is the operator. Intercasting is backed by $17.5M